🇺🇸 FDA
Pipeline program

anti-EGFR monoclonal antibody

CDP100002

Phase 1 small_molecule active

Quick answer

anti-EGFR monoclonal antibody for Healthy Volunteers is a Phase 1 program (small_molecule) at Dragonboat Biopharmaceutical Company Limited with 1 ClinicalTrials.gov record(s).

Program details

Company
Dragonboat Biopharmaceutical Company Limited
Indication
Healthy Volunteers
Phase
Phase 1
Modality
small_molecule
Status
active

Clinical trials